R

Revance

250 employees

Revance Therapeutics develops and commercializes products and treatments for dermatological diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Pharmaceutical

Date founded

2002

Funding rounds raised

Total raised

$300M

from 1 investors over 1 rounds

R

Revance raised $300M on March 21, 2022

Investors: Athyrium Capital Management, LP

FAQ